The IHC staining results demonstrated the low expression of SEZ6L2 in HCT116 tumour tissues from the shSEZ6L2‐1 and shSEZ6L2‐2 groups (Figure 5G). The gene discussed is SEZ6L2; the disease is neoplasm.